Tulane University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tulane University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9289
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tulane University (Tulane) is an educational service provider that provides biomedical courses and research programs. The university provides educational courses in the fields of architecture, business, law, liberal arts, medicine, public health and tropical medicine, science, engineering, and others. It provides training programs for graduate students, postdoctoral fellows, veterinarians, undergraduates, veterinary students and visiting scientists, among others. Tulane conducts basic and applied biomedical research on human health problems. The university offers research work on developing vaccines, and treatments and diagnostic tools for infectious diseases such as Lyme disease, malaria, AIDS, tuberculosis, and others. Tulane is headquartered in New Orleans, Louisiana, the US.

Tulane University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tulane University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tulane University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tulane University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tulane University, Medical Devices Deals, 2012 to YTD 2018 9
Tulane University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tulane University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cyclica Enters into Agreement with Tulane University 11
Licensing Agreements 12
Andarix Pharma Enters into Licensing Agreement with Tulane University 12
AxoSim Technologies Enters into Licensing Agreement with Tulane University 13
Asset Transactions 14
SanBio Acquires Patent Portfolio Regarding Cell Medicines from Tulane University 14
Tulane University – Key Competitors 15
Tulane University – Key Employees 16
Tulane University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Government and Public Interest 19
May 18, 2018: Stroke Researchers Confirm Role of Frontal Lesions in Response to Prism TreatmentHomeStroke 19
Product News 20
07/11/2017: Tulane University awarded $12 million to create Lassa vaccine and treatment 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Tulane University, Pharmaceuticals & Healthcare, Key Facts 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tulane University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tulane University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tulane University, Deals By Therapy Area, 2012 to YTD 2018 8
Tulane University, Medical Devices Deals, 2012 to YTD 2018 9
Tulane University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cyclica Enters into Agreement with Tulane University 11
Andarix Pharma Enters into Licensing Agreement with Tulane University 12
AxoSim Technologies Enters into Licensing Agreement with Tulane University 13
SanBio Acquires Patent Portfolio Regarding Cell Medicines from Tulane University 14
Tulane University, Key Competitors 15
Tulane University, Key Employees 16
Tulane University, Subsidiaries 17

List of Figures
Tulane University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tulane University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tulane University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tulane University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tulane University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tulane University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務情報
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WGL Holdings Inc (WGL):企業の財務・戦略的SWOT分析
    WGL Holdings Inc (WGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sohar Aluminium LLC:企業の戦略・SWOT・財務情報
    Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report Summary Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • illycaffè S.p.A.:企業の戦略・SWOT・財務分析
    illycaffè S.p.A. - Strategy, SWOT and Corporate Finance Report Summary illycaffè S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • Gammon Construction Ltd:企業の戦略的SWOT分析
    Gammon Construction Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Krung Thai Bank PCL:企業の戦略・SWOT・財務分析
    Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report Summary Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Eastern Company SAE:企業の戦略・SWOT・財務情報
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sanyo Chemical Industries Ltd (4471):企業の財務・戦略的SWOT分析
    Sanyo Chemical Industries Ltd (4471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Apache Corporation:企業の戦略・SWOT・財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Merafe Resources Ltd:企業の戦略・SWOT・財務分析
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UCB Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, meta …
  • Global Geophysical Services Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Global Geophysical Services Inc (Global Geophysical) is an oil and gas company that offers geophysical technology solutions. The company offers consulting; reservoir grade 3D data sets and land and marine seismic acquisition; seismic data processing; geophysical, geological and engineering s …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆